CARDIOVASCULAR RISK ESTIMATION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGICS OR C-DMARDS

被引：0
|
作者：
Mole, Evangelia [1 ]
Gazi, Sousana [1 ]
Moschou, Dimitra [1 ]
Mpaili, Georgia [1 ]
Theodorakopoulos, Stavros [1 ]
Zoupidou, Konstantina [1 ]
Kontodimopoulos, Nikolaos [2 ]
机构：
[1] KAT Gen Hosp Attica, Dept Rheumatol, Athens, Greece
[2] KAT Gen Hosp Attica, Div Management, Athens, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.2504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0323
引用
收藏
页码：1620 / 1620
页数：1
相关论文
共 50 条
  • [1] RISK OF MALIGNANCY AND SEVERE INFECTION IN A POPULATION OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS OR DMARDS
    Gilliaux, Q.
    Stoenoiu, M.
    de Bellefon, L. Meric
    Depresseux, G.
    Toukap, A. Nzeusseu
    Lauwerys, B.
    Houssiau, F.
    Durez, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 711 - 712
  • [2] Cardiovascular Disease Risk with Biologics and Tofacitinib Compared to Conventional Synthetic Dmards in Patients with Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Cancers and cardiovascular diseases in patients with seropositive rheumatoid arthritis treated with JAK inhibitors, biologics, and conventional synthetic DMARDs
    Ahn, S. S.
    Han, M.
    Jung, I.
    Kim, H. W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1908 - 1916
  • [4] ARE THE RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICS WITH OR WITHOUT SYNTHETIC DMARDS IN CLINICAL PRACTICE DIFFERENT?
    Hernandez Cruz, B.
    Ariza Ariza, R.
    Caliz Caliz, R.
    Marquez Saavedra, E.
    Navarro Sarabia, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 407 - 407
  • [5] Rheumatoid arthritis: Perioperative management of biologics and DMARDs
    Goodman, Susan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : 627 - 632
  • [6] CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CONVENTIONAL DMARDS: A CLINIC BASED CASE CONTROL STUDY
    Ibragimov, K.
    Ziyadullayev, S.
    Islamova, K.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S419 - S419
  • [7] ESTIMATION OF CARDIOVASCULAR RISK IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Pusineri, Paola
    Cabrera-Villalba, Sonia
    Avila-Pedretti, Gabriela
    Leiva, Evelyn
    Valinotti, Vannia
    Roman, Lourdes
    Acosta-Colman, Isabel
    Martinez, Teresa
    de Abreu, Paloma
    Centurion, Osmar
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S85 - S85
  • [8] A PROSPECTIVE STUDY OF TAPERING CONVENTIONAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS (C-DMARDS) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN STABLE REMISSION
    Romi, Shah
    Balakrishnan, Canchi
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 370 - 371
  • [9] Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
    Zhang, Jie
    Xie, Fenglong
    Yun, Huifeng
    Chen, Lang
    Muntner, Paul
    Levitan, Emily B.
    Safford, Monika M.
    Kent, Shia T.
    Osterman, Mark T.
    Lewis, James D.
    Saag, Kenneth
    Singh, Jasvinder A.
    Curtis, Jeffrey R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (10) : 1813 - 1818
  • [10] The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
    Soo-Kyung Cho
    Jiyoung Lee
    Minkyung Han
    Sang-Cheol Bae
    Yoon-Kyoung Sung
    Arthritis Research & Therapy, 19
12345